neurotensin receptor 1 antagonist (Ipsen)

N/A

Report date: 2025/01/26 17:30:13

Base Information

Drug Nameneurotensin receptor 1 antagonist (Ipsen)

Drug Alias NamePDAC neurotensin receptor antagonist(3B Pharmaceuticals)neurotensin receptor 1 antagonist (3B Pharmaceuticals)NN receptor antagonist(3B Pharmaceuticals)peptide-based SPECT/PET imaging agent (3B Pharmaceuticals)

ClassificationRadiation-emitting productsBiologics > Protein drugs > Recombinant polypeptide

Mechanisms of ActionNeurotensin receptor 1 antagonists

TargetsNeurotensin receptor 1

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesFrance

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator Companies3B Pharmaceuticals GmbH

China Registration ClassN/A

Develop Information

Active CompaniesIpsen SA

Inactive Companies3B Pharmaceuticals GmbH

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A